Will CBO Score CREATE Momentum For Generic Bill's Passage?
Strong savings estimate – and brand pharma's need to have pay-fors for its own legislative priorities – could finally get bill allowing generic companies to sue brand sponsors for access to samples.
You may also be interested in...
AAM President Davis contends he hasn't seen any evidence showing that reference listed drug access inquiries webpage has changed innovator behavior.
Recruiting for “Cures”-funded positions resulted in two hires, then got an HHS review; onboarding time should be reduced significantly, but finding the money to pay the higher salaries remains a challenge under the new process.
PhRMA pushing for legislation to address upcoming surge in Medicare Part D out-of-pocket spending requirements and reverse the recently-enacted increase in the discount on branded drugs in the coverage gap.